James Barber - Graham Independent Director
| GHM Stock | USD 45.05 1.80 4.16% |
Director
Dr. James J. Barber Ph.D., is Independent Director of Graham Corporationration He was an independent consultant and the principal of Barber Advisors, LLC since September 2007. From January 2000 to May 2007, Dr. Barber was the President and CEO of Metabolix, Inc., a bioscience company focused on plastics, chemicals and energy. Dr. Barber is currently, and was since November 2010, a Director of Agrivida, a developer of proprietary crops and processes designed to transform the economics of producing renewable chemicals, fuels, and bioproducts from nonfood cellulosic biomass. And since May 2012, serves as a Director of Allylix Inc., a private renewable chemicals company that develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural and biofuel markets. Prior to joining Metabolix, He served as Global Business Director for the Organometallics and Catalysts business of Albemarle Corporationrationration, a specialty chemicals company. Prior to his tenure at Albemarle, He was Director of Business Development at Ethyl Corporationrationration, a fuel additives company. He also previously served as President of Geltech, Inc., a precision molded micro optics company, and as Chief Operating Officer of Hyperion Catalysis International, a carbon developer and producer. From May through August 2007, He pursued personal interests. Dr. Barber was awarded the American Chemical Societys Henry F. Whalen, Jr. award for Business Development in September 2003. He received his B.S. in Chemistry from Rensselaer Polytechnic Institute and a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology. He also currently serves on the Advancement Council of the College of Polymer Science and Polymer Engineering at the University of Akron since 2011.
| Age | 65 |
| Tenure | 13 years |
| Address | 20 Florence Avenue, Batavia, NY, United States, 14020 |
| Phone | 585 343 2216 |
| Web | https://grahamcorp.com |
Graham Management Efficiency
The company has Return on Asset of 0.0251 % which means that on every $100 spent on assets, it made $0.0251 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0727 %, implying that it generated $0.0727 on every 100 dollars invested. Graham's management efficiency ratios could be used to measure how well Graham manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of December 2024, Return On Tangible Assets is likely to grow to 0.10. Also, Return On Capital Employed is likely to grow to 0.22. At this time, Graham's Debt To Assets are very stable compared to the past year. As of the 11th of December 2024, Fixed Asset Turnover is likely to grow to 5.35, while Total Current Assets are likely to drop about 63.8 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Christopher Lake | Gorman Rupp | 56 | |
| Judith Reinsdorf | Enpro Industries | 57 | |
| John Humphrey | Enpro Industries | 55 | |
| Sonja McClelland | Gorman Rupp | 49 | |
| Diane Creel | Enpro Industries | 72 | |
| Thomas Leonard | Kadant Inc | 66 | |
| Travis Williams | Enerpac Tool Group | N/A | |
| Vincent Petrella | Gorman Rupp | 60 | |
| Erin Russell | Kadant Inc | 47 | |
| Rick Taylor | Gorman Rupp | 73 | |
| Donald Bullock | Gorman Rupp | 61 | |
| John Albertine | Kadant Inc | 76 | |
| Kenneth Reynolds | Gorman Rupp | 62 | |
| Felix Brueck | Enpro Industries | 65 | |
| Cornelis Graaf | Enpro Industries | 71 | |
| Adele Gulfo | Enpro Industries | 58 | |
| Thomas Botts | Enpro Industries | 66 | |
| William Tully | Kadant Inc | 80 | |
Management Performance
| Return On Equity | 0.0727 | |||
| Return On Asset | 0.0251 |
Graham Leadership Team
Elected by the shareholders, the Graham's board of directors comprises two types of representatives: Graham inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Graham. The board's role is to monitor Graham's management team and ensure that shareholders' interests are well served. Graham's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Graham's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Baxter, Senior Vice President - Employee Benefits | ||
| Christopher Thome, Chief Financial Officer, Vice President - Finance | ||
| Cari Jaroslawsky, Director | ||
| Christopher CPA, VP Officer | ||
| Gerard Mazurkiewicz, Independent Director | ||
| Jennifer Condame, Chief Accounting Officer and Controller | ||
| Daniel Thoren, President, Chief Operating Officer | ||
| Jeffrey Glajch, Vice President - Finance and Administration, Chief Financial Officer | ||
| Alan Fortier, Independent Director | ||
| James Lines, President, Chief Executive Officer, Director | ||
| Alan PE, VP GM | ||
| James Malvaso, Non-Executive Independent Chairman of the Board | ||
| Alan Smith, Vice President, General Manager - Batavia | ||
| Jonathan Painter, Chairman of the Board | ||
| James Barber, Independent Director | ||
| Lisa Schnorr, Independent Director | ||
| Matthew Malone, Vice President - Barber-Nichols | ||
| Troy Stoner, Director |
Graham Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Graham a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0727 | |||
| Return On Asset | 0.0251 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 445.81 M | |||
| Shares Outstanding | 10.89 M | |||
| Shares Owned By Insiders | 5.70 % | |||
| Shares Owned By Institutions | 77.89 % | |||
| Number Of Shares Shorted | 109.61 K | |||
| Price To Earning | 37.13 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Graham. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. To learn how to invest in Graham Stock, please use our How to Invest in Graham guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Graham. If investors know Graham will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Graham listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.81 | Earnings Share 0.7 | Revenue Per Share 18.113 | Quarterly Revenue Growth 0.188 | Return On Assets 0.0251 |
The market value of Graham is measured differently than its book value, which is the value of Graham that is recorded on the company's balance sheet. Investors also form their own opinion of Graham's value that differs from its market value or its book value, called intrinsic value, which is Graham's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Graham's market value can be influenced by many factors that don't directly affect Graham's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Graham's value and its price as these two are different measures arrived at by different means. Investors typically determine if Graham is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Graham's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.